Ignite Creation Date:
2025-12-24 @ 3:39 PM
Ignite Modification Date:
2025-12-27 @ 12:08 PM
Study NCT ID:
NCT06095492
Status:
RECRUITING
Last Update Posted:
2024-12-05
First Post:
2023-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus
Sponsor:
Medanta, The Medicity, India
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-30
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-23
First Submit QC Date:
None
Study First Post Date:
2023-10-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-04
Last Update Post Date:
2024-12-05
Last Update Post Date Type:
ACTUAL